M.S. Kies

1.5k total citations
38 papers, 1.1k citations indexed

About

M.S. Kies is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M.S. Kies has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Otorhinolaryngology, 21 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M.S. Kies's work include Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Diagnosis and Treatment (8 papers). M.S. Kies is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Diagnosis and Treatment (8 papers). M.S. Kies collaborates with scholars based in United States, South Africa and Greece. M.S. Kies's co-authors include Bharat B. Mittal, Everett E. Vokes, Harold J. Pelzer, Barry L. Wenig, Daniel J. Haraf, Alfred Rademaker, M.E. Witt, Mark Kozloff, Kerstin Stenson and F. Rosen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M.S. Kies

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.S. Kies United States	16	653	612	527	431	165	38	1.1k
D. Haraf United States	13	478 0.7×	431 0.7×	418 0.8×	325 0.8×	95 0.6×	34	878
C. Tuchais France	14	692 1.1×	572 0.9×	466 0.9×	525 1.2×	166 1.0×	31	1.2k
Iris Gluck Israel	15	369 0.6×	634 1.0×	303 0.6×	307 0.7×	142 0.9×	26	1.0k
S. Chapet France	14	511 0.8×	506 0.8×	603 1.1×	495 1.1×	110 0.7×	48	1.3k
J.M. Melotek United States	10	317 0.5×	554 0.9×	277 0.5×	377 0.9×	67 0.4×	27	892
Mikael Kajanti Finland	18	211 0.3×	326 0.5×	267 0.5×	422 1.0×	113 0.7×	31	852
Robert E. Haselow United States	14	448 0.7×	296 0.5×	378 0.7×	241 0.6×	60 0.4×	18	850
Damon Choy China	16	909 1.4×	722 1.2×	802 1.5×	343 0.8×	98 0.6×	25	1.4k
C Jaulerry France	15	557 0.9×	397 0.6×	361 0.7×	234 0.5×	43 0.3×	37	873
Hao‐Yuan Mo China	16	711 1.1×	598 1.0×	457 0.9×	224 0.5×	294 1.8×	37	1.3k

Countries citing papers authored by M.S. Kies

Since Specialization

Citations

This map shows the geographic impact of M.S. Kies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.S. Kies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.S. Kies more than expected).

Fields of papers citing papers by M.S. Kies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.S. Kies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.S. Kies. The network helps show where M.S. Kies may publish in the future.

Co-authorship network of co-authors of M.S. Kies

This figure shows the co-authorship network connecting the top 25 collaborators of M.S. Kies. A scholar is included among the top collaborators of M.S. Kies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.S. Kies. M.S. Kies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohamed, Abdallah, G. Brandon Gunn, Katherine A. Hutcheson, et al.. (2016). Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT). International Journal of Radiation Oncology*Biology*Physics. 96(2). E335–E336.

Wong, Stuart J., Theodore Karrison, D. Neil Hayes, et al.. (2015). Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Annals of Oncology. 27(2). 318–323. 73 indexed citations

Garden, Adam S., Abdallah Mohamed, Tommy Sheu, et al.. (2015). Prognostic Value of Pretherapy Platelet Elevation in Oropharyngeal Cancer Patients Treated With Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 93(3). E345–E346.

Blumenschein, G. R., Julian R. Molina, Chetan Lathia, et al.. (2011). Phase I dose-escalation study of sorafenib in combination with bevacizumab (B), paclitaxel (P), and carboplatin (C) for the treatment of advanced nonsquamous non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). 7565–7565. 1 indexed citations

Kies, M.S., G. R. Blumenschein, O. Christensen, Tung‐Yi Lin, & Anthony W. Tolcher. (2010). Phase I study of regorafenib (BAY 73-4506), an inhibitor of oncogenic and angiogenic kinases, administered continuously in patients (pts) with advanced refractory non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 28(15_suppl). 7585–7585. 20 indexed citations

Rosenthal, David I., Clifton D. Fuller, M.S. Kies, et al.. (2008). Long-term Outcomes for T4 Larynx Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S415–S415.

Cohen, Ezra E.W., E. Vokes, M.S. Kies, et al.. (2007). 5507 ORAL A phase 2 study of axitinib (AG-013736; AG) in patients (pts) with advanced thyroid cancers. European Journal of Cancer Supplements. 5(4). 326–326. 1 indexed citations

Gillison, M. L., Bonnie S. Glisson, Erin O’Leary, et al.. (2006). Phase II trial of trastuzumab (T), paclitaxel (P) and cisplatin (C) in metastatic (M) or recurrent (R) head and neck squamous cell carcinoma (HNSCC): Response by tumor EGFR and HER2/neu status. Journal of Clinical Oncology. 24(18_suppl). 5511–5511. 18 indexed citations

Kim, E. S., M.S. Kies, Anita L. Sabichi, et al.. (2005). Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 23(16_suppl). 5546–5546. 13 indexed citations

10.

Brockstein, Bruce, Daniel J. Haraf, Alfred Rademaker, et al.. (2004). Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Annals of Oncology. 15(8). 1179–1186. 265 indexed citations

11.

Kies, M.S., Jan S. Lewin, Eduardo M. Diaz, et al.. (2004). Definitive treatment of intermediate stage laryngeal squamous cell (SCC/L) cancer with chemotherapy (CT). Journal of Clinical Oncology. 22(14_suppl). 5533–5533. 3 indexed citations

12.

Bonner, James A., Paul M. Harari, J. Giralt, et al.. (2004). Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab. Journal of Clinical Oncology. 22(14_suppl). 5507–5507. 163 indexed citations

13.

Mantz, C.A., Everett E. Vokes, M.S. Kies, et al.. (2001). Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Annals of Oncology. 12(3). 343–347. 25 indexed citations

14.

Masters, Gregory A., et al.. (2000). A phase I/II study of vinorelbine (NAV) and carboplatin (CARB) for advanced non-small cell lung cancer (NSCLC). Lung Cancer. 29(1). 54–55. 1 indexed citations

15.

Kies, M.S., Daniel J. Haraf, Ilias Athanasiadis, et al.. (1998). Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.. Journal of Clinical Oncology. 16(8). 2715–2721. 75 indexed citations

16.

Vokes, Everett E., Rosemarie Mick, M.S. Kies, et al.. (1996). Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.. Journal of Clinical Oncology. 14(5). 1663–1671. 48 indexed citations

17.

Vokes, Everett E., M.S. Kies, D. Haraf, et al.. (1995). Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.. Journal of Clinical Oncology. 13(4). 876–883. 88 indexed citations

18.

Murthy, Anantha, J.M. Vannetzel, M.S. Kies, et al.. (1995). 104 The five year results of a randomized trial of sequential versus concomitant cisplatin and fluorouracil and radiation in advanced head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 32. 193–193. 1 indexed citations

19.

Mittal, Bharat B., Harold J. Pelzer, William F. Ward, et al.. (1990). Intraoperative Radiation of Canine Carotid Artery, Internal Jugular Vein, and Vagus Nerve: Therapeutic Applications in the Management of Advanced Head and Neck Cancers. Archives of Otolaryngology - Head and Neck Surgery. 116(12). 1425–1430. 14 indexed citations

20.

Taylor, S G, Anantha Murthy, John Showel, et al.. (1989). Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer.. Journal of Clinical Oncology. 7(7). 846–856. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact